Cargando…
PD-L1 in Cytological Samples: A Review and a Practical Approach
With a growing number of predictive biomarkers needed to manage patients with non-small cell lung cancer (NSCLC), there has been a paradigm shift in care and handling of diagnostic samples. Among the various testing methods, immunohistochemistry (IHC) is the most cost- effective and widely available...
Autores principales: | Tejerina, Eva, Garca Tobar, Laura, Echeveste, Jos I., de Andrea, Carlos E., Vigliar, Elena, Lozano, Mara D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139418/ https://www.ncbi.nlm.nih.gov/pubmed/34026795 http://dx.doi.org/10.3389/fmed.2021.668612 |
Ejemplares similares
-
Efficiency of Cytology Samples for PD-L1 Evaluation and Comparison with Tissue Samples
por: Kulaç, İbrahim, et al.
Publicado: (2020) -
Editorial: Advances in Molecular Cytopathology
por: Vigliar, Elena, et al.
Publicado: (2022) -
Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice
por: Sabaté Gallego, Mònica, et al.
Publicado: (2022) -
Cytology in the time of coronavirus disease (COVID-19): an Italian perspective
por: Vigliar, Elena, et al.
Publicado: (2021) -
PD‐L1 and beyond: Immuno‐oncology in cytopathology
por: Iaccarino, Antonino, et al.
Publicado: (2021)